Invanz 1 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers ...

FDA Drug Recall #D-0928-2016 — Class II — April 18, 2016

Recall Summary

Recall Number D-0928-2016
Classification Class II — Moderate risk
Date Initiated April 18, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Baptist Health Medical Towers Pharmacy and Infusion Services
Location Little Rock, AR
Product Type Drugs
Quantity 24 bags

Product Description

Invanz 1 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

Reason for Recall

Lack of Sterility Assurance.

Distribution Pattern

Arkansas

Lot / Code Information

All product remaining within expiry.

Other Recalls from Baptist Health Medical Towers Pharmac...

Recall # Classification Product Date
D-0946-2016 Class II Vancomycin 1750 mg in 270 mL 0.9% NS bag,FOR IV... Apr 18, 2016
D-0943-2016 Class II Vancomycin 1000 mg in 250 mL 0.9% NS bag, FOR I... Apr 18, 2016
D-0926-2016 Class II Ertapenem 1 gram Add-Vantage in a) 50 mL and b)... Apr 18, 2016
D-0911-2016 Class II 0.9% Sodium Chloride a) 500 mL b) 2000 mL and c... Apr 18, 2016
D-0916-2016 Class II Ceftriaxone 1 gram Add-Vantage in a) 50 mL and ... Apr 18, 2016

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.